Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China · Delayed Price · Currency is CNY 37.93
+0.63 (1.69%)
At close: Feb 13, 2026
Lifecome Biochemistry Market Cap
Lifecome Biochemistry has a market cap or net worth of 5.89 billion as of February 13, 2026. Its market cap has increased by 152.03% in one year.
Market Cap
5.89B
Enterprise Value
6.98B
Revenue
587.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.93
Market Cap Chart
Since May 3, 2017, Lifecome Biochemistry's market cap has increased from 2.63B to 5.89B, an increase of 124.41%. That is a compound annual growth rate of 9.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 5.89B | 12.52% |
| Dec 31, 2025 | 5.24B | 68.80% |
| Dec 31, 2024 | 3.10B | -4.84% |
| Dec 29, 2023 | 3.26B | -59.95% |
| Dec 30, 2022 | 8.14B | 381.32% |
| Dec 31, 2021 | 1.69B | -17.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Weiguang Biological Products | 6.51B |
| PharmaResources (Shanghai) | 6.35B |
| Novogene | 6.31B |
| Xiangxue Pharmaceutical | 6.21B |
| Kexing Biopharm | 6.10B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.80B |
| Jiangsu Bioperfectus Technologies | 5.75B |
| ChemPartner PharmaTech | 5.56B |